SCHEMBL20117026

SCHEMBL20117026

CN/C(=N\O)c1ccc2c(c1)c(C)nn2C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.45
ADORA2B P29275 1/20 0.45
CHRM4 P08173 1/20 0.40
GRM4 Q14833 1/20 0.36
QPCT Q16769 1/20 0.35
HTT P42858 3/20 0.35
KDM4E B2RXH2 2/20 0.35
HPGD P15428 2/20 0.35
LMNA P02545 2/20 0.35
MAPT P10636 1/20 0.35
GFER P55789 1/20 0.35
SPR P35270 4/20 0.34
POLB P06746 1/20 0.34
CACNA1H O95180 3/20 0.33
BRD4 O60885 2/20 0.33
CPT2 P23786 1/20 0.33
CPT1A P50416 1/20 0.33
CPT1B Q92523 1/20 0.33
LSS P48449 1/20 0.33
MCHR1 Q99705 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20660789 0.79 ADORA2A (0.47) ADORA2AADORA2BCHRM4GRM4QPCT
SCHEMBL30506277 0.79 ADORA2A (0.47) ADORA2AADORA2BCHRM4GRM4QPCT
SCHEMBL20116622 0.79 ADORA2A (0.47) ADORA2AADORA2BCHRM4GRM4QPCT
SCHEMBL21611310 0.77 ADORA2A (0.45) ADORA2AADORA2BCHRM4GRM4QPCT
SCHEMBL18561359 0.77 ADORA2A (0.47) ADORA2AADORA2BCHRM4KDM4EHPGD
SCHEMBL23535727 0.74 HCAR3 (0.55) ADORA2AADORA2BCHRM4HTTKDM4E
SCHEMBL14595343 0.74 ADORA2A (0.52) ADORA2AADORA2BCHRM4QPCTKDM4E
SCHEMBL30040739 0.74 HCAR3 (0.55) ADORA2AADORA2BCHRM4HTTKDM4E
SCHEMBL20660788 0.74 ADORA2A (0.47) ADORA2AADORA2BCHRM4GRM4QPCT
SCHEMBL29520762 0.73 ADORA2A (0.50) ADORA2AADORA2BCHRM4QPCTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018081167-A1 COMPOUNDS AND USES THEREOF YUMANITY THERAPEUTICS (US) 2018-05-03 WO disclosed